Thyroid Function Test Market : Growing Popularity And Emerging Trends In The Market Forecast 2019 - 2027

The global thyroid function test market was valued at approximately US$ 1.3 Bn in 2018. It is projected to register a cumulative annual growth rate (CAGR) of more than 5% from 2019 to 2027, according to a new report published by Transparency Market Research (TMR) titled 'Thyroid Function Test Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027.' Expansion of the health care industry, increase in health care expenditure, government initiatives, rise in product approvals, and increase in patient population are projected to augment the global market from 2019 to 2027. North America and Western Europe are likely to account for a dominant share of the global thyroid function test market, owing to advancements in healthcare and products and business expansion by various market leaders. Development of health care infrastructure and high medical expenditure by governments in emerging markets, such as China and India, are likely to boost the thyroid function test market in Asia Pacific at a CAGR of around 6.5% from 2019 to 2027.Increasing incidence of thyroid gland disorders to propel marketThe global thyroid function test market is majorly driven by increasing incidence of thyroid disorders such as hypothyroidism and hyperthyroidism. Rise in the number of patients affected with autoimmune diseases (which is the major risk factor for thyroid disorder), such as Grave's disease, is considered a major factor for consistent increase in incidence of thyroid disorder. Organizations such as the World Health Organization (WHO) and the American Association of Clinical Endocrinologists (AACE) have stated that thyroid disorders are rapidly increasing, and they demand novel and effective thyroid therapeutics for treatment. For instance, according to WHO estimates, thyroid disorders such as hypothyroidism, hyperthyroidism, and goiter are common conditions affecting more than 750 million people globally. The Journal of Clinical Endocrinology and Metabolism also estimated that thyroid dysfunction (i.e. hypothyroidism) is the leading endocrine disorder, and accounts for around 30% to 40% of the total endocrine patients. Thus, increase in the prevalence of thyroid disorders drives the demand for thyroid function tests such as TSH, T3, and T4. Additionally, prevalence of these disorders is increasing at a consistent pace in developed countries. This is anticipated to boost sales of thyroid therapeutics. According to the Endocrine Society, around 140 hypothyroidism and 10 hyperthyroidism cases are reported among every 1,000 individuals in the U.S. each year. These factors are expected to fuel the market in the near futureFor More Details, Request A PDF Brochure Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=35750Rise in obese, diabetic, and cardiovascular patientsObese, diabetic, and cardiovascular patients are at a higher risk of developing hypothyroidism and hyperthyroidism. Rise in obese, diabetic, and cardiovascular patients is likely to increase the incidence of thyroid disorders, leading to increase in thyroid function test. Several statistics and clinical studies indicate that thyroid abnormalities are more common in obese, diabetic, and cardiovascular patients. For example, in July 2013, the Journal of Clinical Endocrinology and Metabolism published a cross sectional study of 27,097 volunteers (over 40 years) with body mass index more than 30.0 kg/m2 to assess the risk of hypothyroidism among the obese population. The clinical results of the study supported that thyroid dysfunction is linked to significant changes in body weight, and represents major risk for obese and overweight people. Patients with cardiovascular diseases are also at a high risk of thyroid disorders. A study published in the international journal the Annals of International Medicine noted that hypothyroidism accounted for more than 60% cases of cardiovascular patients such as myocardial infarction and ischemic heart disease. Hence, the factors and statistics mentioned above indicate that increasing obese, diabetic, and cardiovascular populations is likely to propel the thyroid function test marketAsymptomatic nature of thyroid disorders lead to large undiagnosed population to restrain marketThyroid disorders (hypothyroidism and hyperthyroidism) are often overlooked or misdiagnosed, as these disorders do not cause noticeable symptoms or are mistaken for, or attributed to, other medical conditions such as stress and aging. Hence, a large number of patients remain undiagnosed or are suffering from asymptomatic thyroid disorders. The American Thyroid Association stated that thyroid disorders are silent epidemic disorders and more than 50% of thyroid patients are unaware of their conditions.Asia Pacific market to expand significantlyThe market in Asia Pacific is anticipated to expand at an impressive CAGR during the forecast period. The market is estimated to expand at a CAGR of 6.5% during the forecast period. India, China, and Japan are expected to drive the thyroid function test market in Asia Pacific. Increasing prevalence of thyroid disorder in countries such as India and China, increasing awareness regarding early diagnosis and improving economic condition are expected to fuel the market.Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., and Abbott to lead marketThe report also provides profiles of leading players operating in the global thyroid function test market. They include Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., and Abbott. Increase in mergers & acquisitions, strategic collaborations, and new product launches are expected to drive the global market during the forecast period. Additionally, strong product portfolio, high brand recognition, and strong geographic presence are expected to boost the market during the forecast period.

Contact Us

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR's syndicated reports strive to provide clients to serve their overall research requirement.

This release was published on openPR.